Form 8-K - Current report:
SEC Accession No. 0000950170-25-068011
Filing Date
2025-05-09
Accepted
2025-05-09 16:08:00
Documents
12
Period of Report
2025-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20250509.htm   iXBRL 8-K 52492
2 EX-99.1 srzn-ex99_1.htm EX-99.1 217854
  Complete submission text file 0000950170-25-068011.txt   433152

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20250509.xsd EX-101.SCH 46365
15 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20250509_htm.xml XML 6600
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 25930436
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)